A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.
Fiche publication
Date publication
septembre 2017
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric, Pr PEIFFERT Didier, Dr RIOS Maria
Tous les auteurs :
Nesseler JP, Salleron J, Rios M, Nickers P, Marchal F, Brocard F, Peiffert D, Vogin G
Lien Pubmed
Résumé
To evaluate the efficacy and tolerance of adjuvant concurrent chemoradiation (CCRT) as treatment of grade 2 and 3 (G2-3) localized extremity soft tissue sarcomas (STS) by comparing CCRT with standard adjuvant radiation therapy (RT).
Mots clés
Adjuvant treatment, Concurrent chemoradiotherapy, Local control, Soft tissue sarcoma, Toxicity
Référence
Radiother Oncol. 2017 Sep;: